{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:14:02Z","timestamp":1778577242151,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019170","name":"Cabildo de Tenerife","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007757","name":"Agencia Canaria de Investigaci\u00f3n, Innovaci\u00f3n y Sociedad de la Informaci\u00f3n","doi-asserted-by":"publisher","award":["2017010071"],"award-info":[{"award-number":["2017010071"]}],"id":[{"id":"10.13039\/501100007757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bmc.2024.117727","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T21:36:02Z","timestamp":1713821762000},"page":"117727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["1,2,3-Triazole-totarol conjugates as potent PIP5K1\u03b1 lipid kinase inhibitors"],"prefix":"10.1016","volume":"105","author":[{"given":"Samer","family":"Haidar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0753-4251","authenticated-orcid":false,"given":"\u00c1ngel","family":"Amesty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-1498","authenticated-orcid":false,"given":"Sandra","family":"Oramas-Royo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab","family":"El-Awaad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"B\u00f6decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelie","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Aichele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Amaro-Luis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5279-7099","authenticated-orcid":false,"given":"Ana","family":"Est\u00e9vez-Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0666-2676","authenticated-orcid":false,"given":"Joachim","family":"Jose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117727_b0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1152\/physiol.00014.2009","article-title":"Phosphoinositide signaling: new tools and insights","volume":"24","author":"Balla","year":"2009","journal-title":"Physiology"},{"key":"10.1016\/j.bmc.2024.117727_b0010","first-page":"1019","article-title":"Phosphoinositides: tiny lipids with giant impact on cell regulation","volume":"93","author":"Balla","year":"2013","journal-title":"Phys Rev"},{"key":"10.1016\/j.bmc.2024.117727_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BCJ20180022","article-title":"Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids","volume":"476","author":"Dickson","year":"2019","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2024.117727_b0020","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1186\/1471-2148-11-4","article-title":"Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery","volume":"11","author":"Brown","year":"2011","journal-title":"BMC Evolutionary Biology"},{"key":"10.1016\/j.bmc.2024.117727_b0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2024.117727_b0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bmc.2024.117727_b0035","doi-asserted-by":"crossref","first-page":"32937","DOI":"10.1074\/jbc.271.51.32937","article-title":"Type I phosphatidylinositol-4-phosphate 5-kinases are distinct members of this novel lipid kinase family","volume":"271","author":"Loijens","year":"1996","journal-title":"J Bio Chem"},{"key":"10.1016\/j.bmc.2024.117727_b0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117727_b0045","doi-asserted-by":"crossref","first-page":"E3689","DOI":"10.1073\/pnas.1405801111","article-title":"The role of PI3K\/AKT-related PIP5K1alpha and the discovery of its selective inhibitor for treatment of advanced prostate cancer","volume":"111","author":"Semenas","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2024.117727_b0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41388-018-0438-2","article-title":"The role of PIP5K1alpha\/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1alpha inhibitor","volume":"38","author":"Sarwar","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2024.117727_b0055","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1111\/febs.15194","article-title":"Development of an in vitro screening assay for PIP5K1alpha lipid kinase and identification of potent inhibitors","volume":"287","author":"Str\u00e4tker","year":"2020","journal-title":"FEBS J"},{"key":"10.1016\/j.bmc.2024.117727_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.enzmictec.2020.109717","article-title":"Autodisplay of human PIP5K1\u03b1 lipid kinase on Escherichia coli and inhibitor testing","volume":"143","author":"Str\u00e4tker","year":"2021","journal-title":"Enzyme and Microbial Techn"},{"key":"10.1016\/j.bmc.2024.117727_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/metabo2020303","article-title":"A historical overview of natural products in drug discovery","volume":"2","author":"Dias","year":"2012","journal-title":"Metabolites"},{"key":"10.1016\/j.bmc.2024.117727_b0070","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural Products as Sources of New Drugs over the Nearly Four Decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Natl Pro"},{"key":"10.1016\/j.bmc.2024.117727_b0075","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/molecules24071380","article-title":"In Vitro and in Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2","volume":"24","author":"Haidar","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117727_b0080","first-page":"96","article-title":"Rospiglioside, a new totarane diterpene from the leaves of retrophyllum rospigliosii","volume":"50","author":"Amaro-Luis","year":"2006","journal-title":"J Mexican Chem Soc"},{"key":"10.1016\/j.bmc.2024.117727_b0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1071\/CH9950883","article-title":"Totarol: a Non-Conventional Diterpenoid","volume":"48","author":"Bendall","year":"1995","journal-title":"Australian J Chem"},{"key":"10.1016\/j.bmc.2024.117727_b0090","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1055\/s-2003-42778","article-title":"In vitro antiplasmodial activity of abietane and totarane diterpenes isolated from Harpagophytum procumbens (devil's claw)","volume":"69","author":"Clarkson","year":"2003","journal-title":"Planta Medica"},{"key":"10.1016\/j.bmc.2024.117727_b0095","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2672.1996.tb03233.x","article-title":"Antibacterial activity of anacardic acid and totarol, alone and in combination with methicillin, against methicillin-resistant Staphylococcus aureus","volume":"80","author":"Muroi","year":"1996","journal-title":"J App Bacteriol"},{"key":"10.1016\/j.bmc.2024.117727_b0100","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1007\/s10886-007-9390-2","article-title":"The antifungal compound totarol of Thujopsis dolabrata var. hondai seeds selects for fungi on seedling root surfaces","volume":"33","author":"Yamaji","year":"2007","journal-title":"J Chem Ecol"},{"key":"10.1016\/j.bmc.2024.117727_b0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.taap.2015.10.001","article-title":"Totarol prevents neuronal injury in vitro and ameliorates brain ischemic stroke: Potential roles of Akt activation and HO-1 induction","volume":"289","author":"Gao","year":"2015","journal-title":"Toxicol App Pharmacol"},{"key":"10.1016\/j.bmc.2024.117727_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111700","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships","volume":"183","author":"Xu","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117727_b0115","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2024.117727_b0120","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bmcl.2016.12.040","article-title":"Synthesis and biological evaluation of naphthoquinone-coumarin conjugates as topoisomerase II inhibitors","volume":"27","author":"Hueso-Falc\u00f3n","year":"2017","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117727_b0125","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3389\/fphar.2018.01546","article-title":"A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells","volume":"9","author":"Mart\u00edn-Rodr\u00edguez","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2024.117727_b0130","doi-asserted-by":"crossref","first-page":"29679","DOI":"10.18632\/oncotarget.11425","article-title":"CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia","volume":"8","author":"Guerra","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2024.117727_b0135","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.bmc.2017.02.024","article-title":"5-Ethynylarylnaphthalimides as antitumor agents: Synthesis and biological evaluation","volume":"25","author":"Quintana-Espinoza","year":"2017","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2024.117727_b0140","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","article-title":"A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective \u201cligation\u201d of azides and terminal alkynes","volume":"41","author":"Rostovtsev","year":"2002","journal-title":"Angewandte Chemie (Int Ed. in English)"},{"key":"10.1016\/j.bmc.2024.117727_b0145","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.3390\/molecules24213917","article-title":"Synthesis and Antiplasmodial Activity of 1,2,3-Triazole-Naphthoquinone Conjugates","volume":"24","author":"Oramas-Royo","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117727_b0150","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/elps.200900514","article-title":"A CE-based assay for human protein kinase CK2 activity measurement and inhibitor screening","volume":"31","author":"Gratz","year":"2010","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bmc.2024.117727_b0155","doi-asserted-by":"crossref","first-page":"63065","DOI":"10.18632\/oncotarget.11757","article-title":"Targeted suppression of AR-V7 using PIP5K1\u03b1 inhibitor overcomes enzalutamide resistance in prostate cancer cells","volume":"7","author":"Sarwar","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2024.117727_b0160","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117727_b0165","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1042\/BCJ20180326","article-title":"Structural insights into lethal contractural syndrome type 3 (LCCS3) caused by a missense mutation of PIP5Kgamma","volume":"475","author":"Zeng","year":"2018","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2024.117727_b0170","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1073\/pnas.1522112113","article-title":"Mechanism of substrate specificity of phosphatidylinositol phosphate kinases","volume":"113","author":"Muftuoglu","year":"2016","journal-title":"PNAS"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962400141X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962400141X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:31:45Z","timestamp":1778574705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962400141X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":34,"alternative-id":["S096808962400141X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117727","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1,2,3-Triazole-totarol conjugates as potent PIP5K1\u03b1 lipid kinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117727"}}